RN7SL116P

Across TCGA pan-cancer cohorts, RN7SL116P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RN7SL116P’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where RN7SL116P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL116P is over-expressed in tumor, although a few such as LUSC and ESCA show the opposite, repressed pattern.

UCEC, LUSC, and LUAD are the cancer types where RN7SL116P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL116P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	IV	+1.165	.048	2	view →
LUSC	All	All	−0.103	.006	2	view →
LUAD	All	All	+0.303	.044	1	view →
ESCA	Female	All	−0.303	<.001	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RN7SL116P–UCEC

Open the UCEC breakdown →